Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeFrost and SullivanFrost & Sullivan Presents the Unprecedented Opportunities in the Personal Protection Equipment Industry

Frost & Sullivan Presents the Unprecedented Opportunities in the Personal Protection Equipment Industry

The COVID-19 pandemic has caught the world by surprise, and a shortage of personal protective equipment (PPE) has exposed the vulnerability of our healthcare and emergency response systems. While the virus has uncovered industry shortcomings, such as its dependence on outsourced supply chains, demand for PPE is thriving and creating market opportunities globally. According to Frost & Sullivan, on average, the industry grows at 3% to 5% per annum; however, the healthcare PPE segment is now experiencing an unprecedented boom, estimated at 80% to 100%, and is opening doors for new entrants, alliances, and partnership opportunities between PPE players and material suppliers.

Frost & Sullivan invites you to join Global President & Managing Partner Aroop Zutshi and Vice President Sanjiv Bhaskar for the Growth Opportunity briefing, “COVID-19: Growth Opportunities in the PPE Industry,” on May 7 at 11 a.m. EST. The briefing will highlight how the PPE industry can seize the growth opportunities presented and remain a favorite of the private equity community, and also discuss how the pandemic will change the PPE industry’s approach to different end-user industries.

For more information and to register for the webinar, please visit: http://frost.ly/42t

Key benefits of attending this webinar:

  • Understand the impact of COVID-19 on the industrial PPE markets.
  • Identify global opportunities for industrial PPE supplies of masks, gowns and eye protection in the healthcare industry.
  • Expose potential new competitors to industrial PPE players.
  • Discover how to overcome supply chain challenges such as over-dependence on imports.
  • Capitalize on the growing userbase to help your company expand.
  • Find out if COVID-19 will reverse the PPE consolidation trend or enhance it.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy